TY - JOUR
T1 - Capillary electrophoresis-Mass spectrometry at Trial by Metabo-ring
T2 - Effective electrophoretic mobility for Reproducible and Robust Compound Annotation
AU - Drouin, Nicolas
AU - Van Mever, Marlien
AU - Tobolkina, Elena
AU - Ferre, Sabrina
AU - Servais, Anne-Catherine
AU - Gou, Marie-Jia
AU - Nyssen, Laurent
AU - Fillet, Marianne
AU - Lageveen-Kammeijer, Guinevere S M
AU - Nouta, Jan
AU - Chetwynd, Andrew J
AU - Lynch, Iseult
AU - Thorn, James A
AU - Meixner, Jens
AU - Loessner, Christopher
AU - Taverna, Myriam
AU - Liu, Sylvie
AU - Tran, N Thuy
AU - Francois, Yannis Nicolas
AU - Lechner, Antony
AU - Nehmé, Reine
AU - Al Hamoui Dit Banni, Ghassan
AU - Nasreddine, Rouba
AU - Colas, Cyril
AU - Lindner, Herbert H
AU - Faserl, Klaus
AU - Neusüß, Christian
AU - Nelke, Manuel
AU - Laemmerer, Stefan
AU - Perrin, Catherine
AU - Bich, Claudia
AU - Barbas, Coral
AU - López-Gonzálvez, Ángeles
AU - Guttman, Andras
AU - Szigeti, Marton
AU - Britz-McKibbin, Philip
AU - Kroezen, Zachary
AU - Shanmuganathan, Meera
AU - Nemes, Peter
AU - Portero, Erika P
AU - Hankemeier, Thomas
AU - Codesido, Santiago
AU - González-Ruiz, Víctor
AU - Rudaz, Serge
AU - Ramautar, Rawi
PY - 2020/9/22
Y1 - 2020/9/22
N2 - Capillary zone electrophoresis-mass spectrometry (CE-MS) is a mature analytical tool for the efficient profiling of (highly) polar and ionizable compounds. However, the use of CE-MS in comparison to other separation techniques remains underrepresented in metabolomics, as this analytical approach is still perceived as technically challenging and less reproducible, notably for migration time. The latter is key for a reliable comparison of metabolic profiles and for unknown biomarker identification that is complementary to high resolution MS/MS. In this work, we present the results of a Metabo-ring trial involving 16 CE-MS platforms among 13 different laboratories spanning two continents. The goal was to assess the reproducibility and identification capability of CE-MS by employing effective electrophoretic mobility (μ
eff) as the key parameter in comparison to the relative migration time (RMT) approach. For this purpose, a representative cationic metabolite mixture in water, pretreated human plasma, and urine samples spiked with the same metabolite mixture were used and distributed for analysis by all laboratories. The μ
eff was determined for all metabolites spiked into each sample. The background electrolyte (BGE) was prepared and employed by each participating lab following the same protocol. All other parameters (capillary, interface, injection volume, voltage ramp, temperature, capillary conditioning, and rinsing procedure, etc.) were left to the discretion of the contributing laboratories. The results revealed that the reproducibility of the μ
eff for 20 out of the 21 model compounds was below 3.1% vs 10.9% for RMT, regardless of the huge heterogeneity in experimental conditions and platforms across the 13 laboratories. Overall, this Metabo-ring trial demonstrated that CE-MS is a viable and reproducible approach for metabolomics.
AB - Capillary zone electrophoresis-mass spectrometry (CE-MS) is a mature analytical tool for the efficient profiling of (highly) polar and ionizable compounds. However, the use of CE-MS in comparison to other separation techniques remains underrepresented in metabolomics, as this analytical approach is still perceived as technically challenging and less reproducible, notably for migration time. The latter is key for a reliable comparison of metabolic profiles and for unknown biomarker identification that is complementary to high resolution MS/MS. In this work, we present the results of a Metabo-ring trial involving 16 CE-MS platforms among 13 different laboratories spanning two continents. The goal was to assess the reproducibility and identification capability of CE-MS by employing effective electrophoretic mobility (μ
eff) as the key parameter in comparison to the relative migration time (RMT) approach. For this purpose, a representative cationic metabolite mixture in water, pretreated human plasma, and urine samples spiked with the same metabolite mixture were used and distributed for analysis by all laboratories. The μ
eff was determined for all metabolites spiked into each sample. The background electrolyte (BGE) was prepared and employed by each participating lab following the same protocol. All other parameters (capillary, interface, injection volume, voltage ramp, temperature, capillary conditioning, and rinsing procedure, etc.) were left to the discretion of the contributing laboratories. The results revealed that the reproducibility of the μ
eff for 20 out of the 21 model compounds was below 3.1% vs 10.9% for RMT, regardless of the huge heterogeneity in experimental conditions and platforms across the 13 laboratories. Overall, this Metabo-ring trial demonstrated that CE-MS is a viable and reproducible approach for metabolomics.
UR - http://www.scopus.com/inward/record.url?scp=85096830637&partnerID=8YFLogxK
U2 - 10.1021/acs.analchem.0c03129
DO - 10.1021/acs.analchem.0c03129
M3 - Article
C2 - 32961048
SN - 0003-2700
VL - 92
SP - 14103
EP - 14112
JO - Analytical Chemistry
JF - Analytical Chemistry
IS - 20
ER -